Artificial Intelligence (AI) in MRI Market (By Clinical Application: Breast, Lung, Neurology, Cardiovascular, Liver, Prostate, Colon, Musculoskeletal, Others; By Solution: Hardware, Software, Services; By Technology: Speech Recognition, Querying Method, Natural Language Processing, Machine Learning, Context Aware Processing; By End User: Hospitals, Pharmaceutical Organizations, Diagnostic Centers, Clinics; Deployment Type) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. End-User Procurement Analysis 

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Artificial Intelligence (AI) in MRI Market 

5.1. COVID-19 Landscape: Artificial Intelligence (AI) in MRI Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Artificial Intelligence (AI) in MRI Market, By Application

8.1. Artificial Intelligence (AI) in MRI Market, by Application, 2022-2030

8.1.1. X-Ray

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. CT

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. MRI

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Ultrasound

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Molecular Imaging

8.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Artificial Intelligence (AI) in MRI Market, By Clinical Applications

9.1. Artificial Intelligence (AI) in MRI Market, by Clinical Applications, 2022-2030

9.1.1. Breast

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Lung

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Neurology

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Cardiovascular

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Liver

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Prostate

9.1.6.1. Market Revenue and Forecast (2017-2030)

9.1.7. Colon

9.1.7.1. Market Revenue and Forecast (2017-2030)

9.1.8. Musculoskeletal

9.1.8.1. Market Revenue and Forecast (2017-2030)

9.1.9. Others

9.1.9.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Artificial Intelligence (AI) in MRI Market, By Offering

10.1. Artificial Intelligence (AI) in MRI Market, by Offering, 2022-2030

10.1.1. Hardware

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Software

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Services

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Artificial Intelligence (AI) in MRI Market, By Technology

11.1. Artificial Intelligence (AI) in MRI Market, by Technology, 2022-2030

11.1.1. Deep Learning

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Computer Vision

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. NLP

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Artificial Intelligence (AI) in MRI Market, By Deployment Type

12.1. Artificial Intelligence (AI) in MRI Market, by Deployment Type, 2022-2030

12.1.1. On-Premise

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Cloud

12.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Artificial Intelligence (AI) in MRI Market, By End-User

13.1. Artificial Intelligence (AI) in MRI Market, by End-User, 2022-2030

13.1.1. Hospitals

13.1.1.1. Market Revenue and Forecast (2017-2030)

13.1.2. Clinics

13.1.2.1. Market Revenue and Forecast (2017-2030)

13.1.3. Research Laboratories

13.1.3.1. Market Revenue and Forecast (2017-2030)

13.1.4. Others

13.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 14. Global Artificial Intelligence (AI) in MRI Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Application (2017-2030)

14.1.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.1.3. Market Revenue and Forecast, by Offering (2017-2030)

14.1.4. Market Revenue and Forecast, by Technology (2017-2030)

14.1.5. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.1.6. Market Revenue and Forecast, by End-User (2017-2030)

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Application (2017-2030)

14.1.7.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.1.7.3. Market Revenue and Forecast, by Offering (2017-2030)

14.1.7.4. Market Revenue and Forecast, by Technology (2017-2030)

14.1.8. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.1.8.1. Market Revenue and Forecast, by End-User (2017-2030) 

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Application (2017-2030)

14.1.9.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.1.9.3. Market Revenue and Forecast, by Offering (2017-2030)

14.1.9.4. Market Revenue and Forecast, by Technology (2017-2030)

14.1.10. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.1.11. Market Revenue and Forecast, by End-User (2017-2030)

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Forecast, by Application (2017-2030)

14.2.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.2.3. Market Revenue and Forecast, by Offering (2017-2030)

14.2.4. Market Revenue and Forecast, by Technology (2017-2030) 

14.2.5. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.2.6. Market Revenue and Forecast, by End-User (2017-2030)

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Application (2017-2030)

14.2.8.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.2.8.3. Market Revenue and Forecast, by Offering (2017-2030)

14.2.9. Market Revenue and Forecast, by Technology (2017-2030) 

14.2.10. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.2.10.1. Market Revenue and Forecast, by End-User (2017-2030) 

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Application (2017-2030)

14.2.11.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.2.11.3. Market Revenue and Forecast, by Offering (2017-2030)

14.2.12. Market Revenue and Forecast, by Technology (2017-2030)

14.2.13. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.2.14. Market Revenue and Forecast, by End-User (2017-2030)

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Application (2017-2030)

14.2.15.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.2.15.3. Market Revenue and Forecast, by Offering (2017-2030)

14.2.15.4. Market Revenue and Forecast, by Technology (2017-2030)

14.2.16. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.2.16.1. Market Revenue and Forecast, by End-User (2017-2030)

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Application (2017-2030)

14.2.17.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.2.17.3. Market Revenue and Forecast, by Offering (2017-2030)

14.2.17.4. Market Revenue and Forecast, by Technology (2017-2030)

14.2.18. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.2.18.1. Market Revenue and Forecast, by End-User (2017-2030)

14.3. APAC

14.3.1. Market Revenue and Forecast, by Application (2017-2030)

14.3.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.3.3. Market Revenue and Forecast, by Offering (2017-2030)

14.3.4. Market Revenue and Forecast, by Technology (2017-2030)

14.3.5. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.3.6. Market Revenue and Forecast, by End-User (2017-2030)

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Application (2017-2030)

14.3.7.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.3.7.3. Market Revenue and Forecast, by Offering (2017-2030)

14.3.7.4. Market Revenue and Forecast, by Technology (2017-2030)

14.3.8. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.3.9. Market Revenue and Forecast, by End-User (2017-2030)

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Application (2017-2030)

14.3.10.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.3.10.3. Market Revenue and Forecast, by Offering (2017-2030)

14.3.10.4. Market Revenue and Forecast, by Technology (2017-2030)

14.3.11. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.3.11.1. Market Revenue and Forecast, by End-User (2017-2030)

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Application (2017-2030)

14.3.12.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.3.12.3. Market Revenue and Forecast, by Offering (2017-2030)

14.3.12.4. Market Revenue and Forecast, by Technology (2017-2030)

14.3.12.5. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.3.12.6. Market Revenue and Forecast, by End-User (2017-2030)

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Application (2017-2030)

14.3.13.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.3.13.3. Market Revenue and Forecast, by Offering (2017-2030)

14.3.13.4. Market Revenue and Forecast, by Technology (2017-2030)

14.3.13.5. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.3.13.6. Market Revenue and Forecast, by End-User (2017-2030)

14.4. MEA

14.4.1. Market Revenue and Forecast, by Application (2017-2030)

14.4.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.4.3. Market Revenue and Forecast, by Offering (2017-2030)

14.4.4. Market Revenue and Forecast, by Technology (2017-2030)

14.4.5. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.4.6. Market Revenue and Forecast, by End-User (2017-2030)

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Application (2017-2030)

14.4.7.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.4.7.3. Market Revenue and Forecast, by Offering (2017-2030)

14.4.7.4. Market Revenue and Forecast, by Technology (2017-2030)

14.4.8. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.4.9. Market Revenue and Forecast, by End-User (2017-2030)

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Application (2017-2030)

14.4.10.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.4.10.3. Market Revenue and Forecast, by Offering (2017-2030)

14.4.10.4. Market Revenue and Forecast, by Technology (2017-2030)

14.4.11. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.4.12. Market Revenue and Forecast, by End-User (2017-2030)

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Application (2017-2030)

14.4.13.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.4.13.3. Market Revenue and Forecast, by Offering (2017-2030)

14.4.13.4. Market Revenue and Forecast, by Technology (2017-2030)

14.4.13.5. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.4.13.6. Market Revenue and Forecast, by End-User (2017-2030)

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Application (2017-2030)

14.4.14.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.4.14.3. Market Revenue and Forecast, by Offering (2017-2030)

14.4.14.4. Market Revenue and Forecast, by Technology (2017-2030)

14.4.14.5. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.4.14.6. Market Revenue and Forecast, by End-User (2017-2030)

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Application (2017-2030)

14.5.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.5.3. Market Revenue and Forecast, by Offering (2017-2030)

14.5.4. Market Revenue and Forecast, by Technology (2017-2030)

14.5.5. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.5.6. Market Revenue and Forecast, by End-User (2017-2030)

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Application (2017-2030)

14.5.7.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.5.7.3. Market Revenue and Forecast, by Offering (2017-2030)

14.5.7.4. Market Revenue and Forecast, by Technology (2017-2030)

14.5.8. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.5.8.1. Market Revenue and Forecast, by End-User (2017-2030)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Application (2017-2030)

14.5.9.2. Market Revenue and Forecast, by Clinical Applications (2017-2030)

14.5.9.3. Market Revenue and Forecast, by Offering (2017-2030)

14.5.9.4. Market Revenue and Forecast, by Technology (2017-2030)

14.5.9.5. Market Revenue and Forecast, by Deployment Type (2017-2030)

14.5.9.6. Market Revenue and Forecast, by End-User (2017-2030)

Chapter 15. Company Profiles

15.1. BenevolentAI

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. OrCam

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Babylon

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Freenome Inc.

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Clarify Health Solutions

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. BioXcel Therapeutics

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Ada Health GmbH

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. GNS Healthcare

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Zebra Medical Vision Inc.

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Qventus Inc

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms